Comparison of intrahepatic and pancreatic perfusion on fusion images using a combined SPECT/CT system and assessment of efficacy of combined continuous arterial infusion and systemic chemotherapy in advanced pancreatic carcinoma

CardioVascular and Interventional Radiology

Volumn 30, Issue 5, 2007, Pages 912-921

  Ikeda, Osama ^a   Tamura, Yoshitaka ^a   Nakasone, Yutaka ^a   Shiraishi, Shinya ^a   Kawanaka, Kouichi ^a   Tomiguchi, Seiji ^a   Yamashita, Yasuyuki ^a   Takamori, Hiroshi ^a   Kanemitsu, Keiichiro ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Fusion image; Pancreatic carcinoma; Reservoir

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ANALYTIC METHOD; ANGIOGRAPHY; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CHI SQUARE TEST; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LOG RANK TEST; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, PANCREATIC DUCTAL; CATHETERS, INDWELLING; CHEMOEMBOLIZATION, THERAPEUTIC; DEOXYCYTIDINE; EQUIPMENT DESIGN; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; KAPLAN-MEIERS ESTIMATE; LIVER CIRCULATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 34848899474     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-007-9134-2     Document Type: Article

References (48)

1. Zimmerman SE, Smith FP, Scein PS (1981) Chemotherapy of pancreatic carcinoma. Cancer 47:1724-1728
2. Nagakawa T, Kobayashi H, Ueno K, Ohta T, Kayahara M, Miyazaki (1994) Clinical study of the lymphatic flow to pancreatic lymph nodes in carcinoma of the head of the pancreas. Cancer 73:1155-1162
3. Hansen R, Quebbeman E, Ritch P, Chitamber C, Anderson T (1988) Continuous 5-FU infusion in carcinoma of the pancreas. Am J Med Sci 295:91-93
4. Auerbach M, Wampler GL, Lockich JJ, Fryer D, Fryer JG, Ahlgren JD (1997) Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-FU plus weekly cisplatin for pancreatic carcinoma. A Mid Atlantic Oncology Program Study. Ann Oncol 8:439-444
5. Carmichael J (1997) Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine. Digestion 58:503-507
6. Rothenberg ML, Moore MJ, Cripps MC, et al. (1996) A phase II trial of gemicitabine in patients with 5-FU refractory pancreas cancer. Ann Oncol 7:347-353
7. Burris HA, Moore MJ, Andersen J, et al. (1997) Improvements in survival and clinical benefits gemicitabine as first-line therapy for patients with advanced pancreatic cancer. J Clin Oncol 15:2403-2413
8. Muchmore JH, Perslan JE, George WJ (1996) Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 78 (Suppl 3):664-667
9. Civelek AC, Sitzmann JV, Chin BB, et al. (1993) Misperfusion of the liver during hepatic artery infusion chemotherapy: value of preoperative angiography and post operative pump scintigraphy. Am J Roentgenol 160:865-870
10. Ikeda O, Kusunoki S, Nakaura T, et al. (2004) Evaluation of fusion imaging using a combined SPECT/CT system; assessment of drug distribution in patients whose catheter was fixed into a branch of the hepatic artery. J Vasc Interv Radiol 19:393-397
11. Seki H, Kimura M, Kamura T, et al. (1996) Hepatic perfusion abnormalities during treatment with hepatic arterial infusion chemotherapy: value of CT arteriography using an implantable port system. J Comput Assist Tomogr 20:343-348
12. Morimoto M, Satake M, Sekiguchi R, et al. (1999) Optimal injection protocol for CT evaluation during hepatic arterial infusion chemotherapy. Invest Radiol 34:744-750
13. 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf) 59(5):565-573
14. Even-Sapir E, Lerman H, Lievshitz G, et al. (2003) Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 44(9):1413-1420
15. Koral KF, Dewaraja Y, Li J, et al. (2003) Update on hybrid conjugate view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients. J Nucl Med 44(3):457-464
16. Ikeda O, Kusunoki S, Kudoh K, et al (2006) Evaluation of the efficacy of combined continuous arterial infusion and systemic chemotherapy for the treatment of advanced pancreatic carcinoma. Cardiovasc Interv Radiol 29(3):362-370
17. Ikeda O, Kusunoki S, Nakaura T, et al (2006) Comparison of fusion imaging using a combined SPECT/CT system and intra-arterial CT: assessment of drug distribution by an implantable port system in patients undergoing hepatic arterial infusion chemotherapy. Cardiovasc Interv Radiol. 29(3):371-379
18. Niederhuber JE, Brennan MF, Menck HR (1995) The National Cancer Data Base Report on pancreatic cancer. Cancer 76:1671-1677
19. Bakkevold KE, Amesjo B, Dahl O, Kambestad B (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: results of a controlled, prospective randomized multicentre study. Eur J Cancer 29A:698-703
20. Arbuck SG (1990) Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 7:209-212
21. Wagener DJT, Hoogenraad WJ, Rougier P, et al. (1996) Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer. An EORTC GITCCG study. Eur J Cancer 32A:1310-1313
22. Muchmore JH, Preslan JE, George WJ (1996) Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 78:664-673
23. Douglass H (1993) Current approaches to multimodality management of advanced pancreatic cancer. Hepato-Gastroenterology 40:433-442
24. Gudjonsson B (1995) Carcinoma of pancreas: critical analysis of cost, results of resection, and the need for standardized reporting. J Am Coll Surg 181:483-453
25. Zimmeman SE, Smith FP, Scein PS (1981) Chemotherapy of pancreatic carcinoma. Cancer 47:1724-1728
26. Gastrointestinal Tumor Study Group (1981) Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 48:1705-1715
27. Cantore M, Fiorentini G, Bassi C, et al. (1997) Intra-arterial chemotherapy for stage-III/IV pancreatic cancer. Dig Surg 14:113-118
28. Cohen L, Hendrickson FR, Lennox AJ, Kroc TK, Hatcher MA, Bennett BR (1996) Pancreatic cancer: treatment with neutron irradiation alone and with chemotherapy. Radiology 200:627-630
29. Palmer KR, Kerr M, Knowles G, Cull A, Carter DC, Leonard RCF (1994) Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg 81:882-885
30. Evans TRJ, Lofts FJ, Mansi JL, Glees JP, Dalgleish AG, Knight MJ (1996) A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. Br J Cancer 73:1260-1264
31. Ishikawa O, Ohigashi H, Sasaki Y, et al. (1994) Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 168:361-364
32. Ishida H, Makino T, Kobayashi M, Tsuneoka K (1983) Laparoscopic measurement of pancreatic blood flow. Endoscopy 15:107-110
33. Aigner KR, Muller H, Basserman R (1990) Intra-arterial chemotherapy with MMC, CDDP and 5-FU for nonresectable pancreatic cancer. A phase II study. Reg Cancer Treat 3:1-6
34. Muchmore JH (1995) Treatment of advanced pancreatic cancer with regional chemotherapy plus hemofiltration. Int J Pancreatol 7:209-222
35. Gansauge F, Link KH, Rilinger N, Kunz R, Beger HG (1995) Regional chemotherapy in advanced pancreatic carcinoma. Med Klin 90:501-515
36. Link KH, Gansauge F, Rilinger N, Beger HG (1997) Celiac artery adjuvant chemotherapy. Results of a prospective trial. Int J Pancreatol 21:65-69
37. Cantore M, Fiorentini G, Bassi C, et al. (1996) Intra-arterial chemotherapy for locally advanced and metastatic pancreatic cancer. J Chemother 8:80-83
38. Link KH, Gansauge F, Gorich J, Leder GH, Rilinger N, Beger HG (1997) Palliative and adjuvant regional chemotherapy in pancreatic cancer. Eur J Surg Oncol 23:409-414
39. Beger HG, Gansauge F, Buchler MW, Link KH (1999) Intra-arterial adjuvant chemotherapy after pancreaticoduodectomy for pancreatic cancer: Significant reduction in occurrence of liver metastases. World J Surg 23:946-949
40. Archer SG, Gray BN (1989) Vascularization of small liver metastases. Br J Surg 76:545-548
41. Kemeny NE (1995) Regional chemotherapy of colorectal cancer. Eur J Cancer 31A:1271-1276
42. Burris HA III, Moore MJ, Andersen J, et al. (1997) Improvenments in survival and clinical benefits with gemicitabine as first-line therapy for patients with advanced pancreatic cancer: a randomized trial. J Clin Oncol 15: 2403-2413
43. Zanon C, Alabiso O, Grosso M, et al. (2000) Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer. Int J Pancreatol 27:225-233
44. Takamori H, Kanemitsu K, Tsuji T, et al. (2005) 5-Fluorouracil intra-arterial infusion combined with systemic gemicitabine for unresectable pancreatic cancer. Pancreas 30:223-226
45. Civelek AC, Sitzmann JV, Chin BB, et al. (1993) Misperfusion of the liver during hepatic artery infusion chemotherapy: value of preoperative angiography and post operative pump scintigraphy. Am J Roentgenol 160:865-870
46. Honma H, Doi T, Mezawa S, et al. (2000) A novel infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Cancer 89:303-313
47. Ikeda O, Tamura Y, Nakasone Y, et al. (2007) Evaluation of intrahepatic perfusion on fusion imaging using a combined CT/SPECT system: influence of anatomic variations on hemodynamic modification before installation of implantable port systems for hepatic arterial infusion chemotherapy. Cardiovasc Interv Radiol 30(3):383-391
48. Ikeda O, Tamura Y, Nakasone Y, et al. (2007) Evaluation of extrahepatic perfusion of anticancer drugs in the right gastric arterial region on fused images using combined CT/SPECT: Is extrahepatic perfusion predictive of gastric toxicity? Cardiovasc Interv Radiol 30(3):392-397